MedCity News June 8, 2023
Dr. Joel Diamond

By continuing an open discussion on precision medicine and precision care, we can truly accelerate pharmacogenomic testing to its full potential and focus on providing the highest quality care to those who need it most.

Recently, I saw a patient concerned about their family history of colon cancer. As a family physician familiar with genetics, I obtained a thorough family history and discussed the potential for Lynch Syndrome, the most common cause of hereditary colorectal cancer. I recognized the need for better electronic medical record support for documenting a family pedigree, as well as the need for more decision support in recognizing a condition that can be detected early with appropriate screening. Lynch syndrome increases an individual’s risk of developing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Physician, Precision Medicine, Provider
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article